Bepotastine besilate clinical trials
Also written Bepreve and TALION®.
How each study uses bepotastine besilate is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- 8 Sept 2009 · BEPREVE · NDA 022288 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
16 studies that test it; most in 2013 (4)
| Year | Studies |
|---|---|
| 2007 | 3 |
| 2010 | 3 |
| 2011 | 2 |
| 2013 | 4 |
| 2014 | 1 |
| 2017 | 1 |
| 2020 | 1 |
| 2021 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 13 · Other 3
Bausch & Lomb Incorporated (6) · Tanabe Pharma Corporation (3) · Laboratorios Sophia S.A de C.V. (1) · Laboratorios Poen (1) · Southern California College of Optometry at Marshall B. Ketchum University (1) · Dong-A ST Co., Ltd. (1) · Daewoong Pharmaceutical Co. LTD. (1) · McCabe Vision Center (1)
Often tested with
Tested in the same studies.
Loteprednol Etabonate (1) · DA-5206 (1) · Olopatadine (1)
Related medicines
As reviewed, each with the page that says it.
- One of Antihistamines source
Studies
Open first, then newest update. How each study uses bepotastine besilate is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 16
- The Confirmatory Study of TAU-284 in Pediatric Patients With Perennial Allergic RhinitisCompletedPhase 3Tanabe Pharma CorporationNCT01861522Written as Bepotastine besilateHow we know
- A Confirmatory Study of TAU-284 in Pediatric Patients With Atopic DermatitisCompletedPhase 3Tanabe Pharma CorporationNCT01840605Written as Bepotastine besilateHow we know
- A Long-Term Study of TAU-284 in Pediatric Patients With Perennial Allergic RhinitisCompletedPhase 3Tanabe Pharma CorporationNCT01900054Written as Bepotastine besilateHow we know
- Clinical Study for the Evaluation of Safety and Tolerability of PRO-172 Ophthalmic Solution+CompletedPhase 1Laboratorios Sophia S.A de C.V.NCT04693429Written as Bepotastine BesilateHow we know
- Efficacy and Toxicity of Bepotastine 1,5% PF vs Olopatadine 0,2% With BAK on Allergic Conjunctivitis TreatmentCompletedPhase 4Laboratorios PoenNCT04776096Written as Bepotastine Besilate 1.5% PFHow we know
- Bepotastine Besilate Nasal Sprays in the Treatment of Seasonal Allergic Rhinitis (SAR)CompletedPhase 2Bausch & Lomb IncorporatedNCT01753739Written as Bepotastine besilateHow we know
- Safety and Efficacy of Bepotastine Besilate Nasal Spray in the Treatment of Seasonal Allergic RhinitisCompletedPhase 2Bausch & Lomb IncorporatedNCT01277341Written as Bepotastine Besilate Nasal Spray 2% Twice a dayHow we know
- Safety and Efficacy of Bepotastine Besilate Ophthalmic Solution in Seasonal Allergic Conjunctivitis PatientsCompletedPhase 2Bausch & Lomb IncorporatedNCT01174823Written as bepotastine besilate ophthalmic solutionHow we know
- Bepreve vs. Alrex in Subjects With Moderate to Severe Allergic ConjunctivitisCompletedPhase 4Southern California College of Optometry at Marshall B. Ketchum UniversityNCT01443442Written as bepotastine besilate, 1.5%How we know
- Pharmacokinetics and Safety/Tolerability Profiles of DA-5206 Versus Talion® Under Fasting and Fed States in Healthy Male SubjectsCompletedPhase 1Dong-A ST Co., Ltd.NCT03200496Written as TALION®How we know
- Drug Interaction Study Between Erdosteine and Bepotastine Besilate in Healthy Adult VolunteersCompletedPhase 1Daewoong Pharmaceutical Co. LTD.NCT02332044Written as TalionHow we know
- Comparing Patient Satisfaction With Pataday or BepreveCompletedNot applicableMcCabe Vision CenterNCT01450176Written as Bepotastine besilate ophthalmic solution 1.5%How we know
- Safety Study for Bepotastine Besilate Ophthalmic Solution in Normal VolunteersCompletedPhase 3Bausch & Lomb IncorporatedNCT00586625Written as BepreveHow we know
- Evaluation of the Onset and Duration of Action of Bepotastine Besilate Ophthalmic Solution in Acute Allergic ConjunctivitisCompletedPhase 2/3Bausch & Lomb IncorporatedNCT00424398Written as BepreveHow we know
- Efficacy and Safety Study of Bepotastine Besilate Ophthalmic Solution in Allergic ConjunctivitisCompletedPhase 3Bausch & Lomb IncorporatedNCT00586664Written as Bepreve (bepotastine besilate ophthalmic solution) 1.5%How we know
- The Evaluation of Bepreve on the Measurement of Wheal and Flare Response From Histamine Skin Prick TestingCompletedPhase 4North Texas Institute for Clinical TrialsNCT01128556Written as BepreveHow we know
Codes
What other systems call bepotastine besilate · ClinicalTrials.gg INT004934
- MeSH (NLM) C511534bepotastine besilateConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 6W18MO1QR3BEPOTASTINE BESYLATEConfirmed FDA, NLM, Wikidata
- RxNorm 658552Confirmed FDA, Wikidata
- Wikidata Q27114261bepotastine besilateConfirmed FDA, NLM, Wikidata
- DrugBank DBSALT000017One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C511534 | bepotastine besilate | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 6W18MO1QR3 | BEPOTASTINE BESYLATE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 658552 | — | Confirmed FDA, Wikidata |
| Wikidata | Q27114261 | bepotastine besilate | Confirmed FDA, NLM, Wikidata |
| DrugBank | DBSALT000017 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.